| 000 | 01439 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516013630.0 | ||
| 264 | 0 | _c20110503 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/092986711794088326 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcDonald, C L | |
| 245 | 0 | 0 |
_aTargeting the Nogo receptor complex in diseases of the central nervous system. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2011 |
||
| 300 |
_a234-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xetiology |
| 650 | 0 | 4 |
_aGPI-Linked Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xetiology |
| 650 | 0 | 4 |
_aMyelin Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNervous System Diseases _xmetabolism |
| 650 | 0 | 4 | _aNogo Receptor 1 |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSpinal Cord Injuries _xetiology |
| 700 | 1 | _aBandtlow, C | |
| 700 | 1 | _aReindl, M | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 18 _gno. 2 _gp. 234-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986711794088326 _zAvailable from publisher's website |
| 999 |
_c20403550 _d20403550 |
||